PATHOVACS

PathoVacs was founded in 2009 with the goal of commercializing technology invented at the Harvard University / Massachusetts General Hospital. Our strategy includes the development of proprietary vaccines, novel diagnostics, and also contract discovery research... Our mission is developing new efficacious universal protein subunit vaccines for infectious agents that are a major public health concern worldwide, and novel diagnostics for both infectious and neuro-degenerative diseases.

Also known as: Pathovacs, Inc.

Primary location: Ames United States